Stocks · News reference
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.39) by 50 percent. This is a 92.08 percent increase over losses of $(2.40) per share
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-08-12 AccNo: 0001437749-26-027356 Size: 337 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgar